Novocell CEO Moves to Nonprofit Juvenile Diabetes Research Foundation

The New York-based Juvenile Diabetes Research Foundation has named San Diego-based Novocell CEO Alan Lewis as its new chief executive. Lewis plans to step down from Novocell, a stem cell company developing a treatment for Type 1 diabetes, on Jan. 1. Lewis told The San Diego Union-Tribune Novocell is in a good financial shape to continue its move into clinical trials.

Bruce V. Bigelow was the editor of Xconomy San Diego from 2008 to 2018. Read more about his life and work here. Follow @bvbigelow

Trending on Xconomy